Net Medical Xpress Solutions, Inc. (NMXS) Hisse Analizi
Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
NMXS, $ (piyasa değeri 0) fiyatla Healthcare işi olan Net Medical Xpress Solutions, Inc.'i temsil ediyor. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 39/100 (ihtiyatlı) olarak derecelendirilmiştir.
Son analiz: 17 Mar 2026Net Medical Xpress Solutions, Inc. (NMXS) Sağlık ve Boru Hattı Genel Bakışı
Net Medical Xpress Solutions, Inc. delivers telemedicine solutions, including its Telemed platform, to hospitals and nursing homes, specializing in areas like teleneurology and telecardiology. Operating in the healthcare information services sector, the company integrates with existing EMR systems to enhance remote patient care and physician support.
Yatırım Tezi
Net Medical Xpress Solutions, Inc. operates in the growing telemedicine market, but its financial performance raises concerns. With a negative profit margin of -311.1% and a negative gross margin of -10.1%, the company's profitability is a significant challenge. The company's Telemed platform and integration services could drive future growth, but the current financial metrics suggest a need for improved operational efficiency and revenue generation. The company's small size (23 employees) and OTC listing add to the risk profile. Investors should closely monitor the company's ability to improve its financial performance and capitalize on the telemedicine market's growth potential.
FMP finansallarına ve nicel analizine dayanmaktadır
Temel Önemli Noktalar
- Market Cap of $0.00B indicates a micro-cap company with limited financial resources.
- P/E Ratio of -0.01 suggests the company is not currently profitable.
- Profit Margin of -311.1% reflects significant losses relative to revenue.
- Gross Margin of -10.1% indicates that the company's cost of goods sold exceeds its revenue.
- Beta of -1.85 suggests the stock price moves inversely to the market, and with greater volatility.
Rakipler & Benzerleri
Güçlü Yönler
- Specialized telemedicine services in areas like teleneurology and telecardiology.
- Proprietary Telemed platform offering customizable telemedicine management.
- Integration capabilities with approximately 43 hospital-based EMR systems.
- Offers a range of services including staffing, recruiting, and diagnostic services.
Zayıflıklar
- Negative profit margin and gross margin indicate financial instability.
- Small market capitalization limits access to capital.
- Limited number of employees (23) may constrain growth potential.
- OTC listing increases risk and reduces liquidity.
Katalizörler
- Ongoing: Expansion of telemedicine services into new medical specialties.
- Ongoing: Strategic partnerships with hospitals and healthcare systems.
- Ongoing: Development of remote patient monitoring solutions.
- Upcoming: Potential integration of AI and machine learning into the Telemed platform.
- Upcoming: Geographic expansion into international markets.
Riskler
- Ongoing: Negative profit margin and gross margin indicate financial instability.
- Ongoing: Small market capitalization limits access to capital.
- Potential: Intense competition from established telemedicine providers.
- Potential: Evolving regulatory landscape for telemedicine.
- Potential: Cybersecurity risks associated with remote healthcare delivery.
Büyüme Fırsatları
- Expansion of Telemedicine Services: The telemedicine market is experiencing substantial growth, driven by increased demand for remote patient monitoring and virtual consultations. Net Medical Xpress Solutions can capitalize on this trend by expanding its Telemed platform's capabilities and targeting new medical specialties. By offering specialized telemedicine solutions for areas like dermatology or mental health, the company can attract new clients and increase revenue streams. The global telemedicine market is projected to reach $460 billion by 2030, presenting a significant opportunity for growth.
- Strategic Partnerships with Hospitals and Healthcare Systems: Collaborating with hospitals and healthcare systems can provide Net Medical Xpress Solutions with access to a broader patient base and established referral networks. By integrating its Telemed platform with existing hospital EMR systems, the company can streamline workflows and improve patient care coordination. These partnerships can also lead to long-term contracts and recurring revenue streams. Focus on hospitals in rural areas or with limited access to specialists could be a particularly effective strategy.
- Development of Remote Patient Monitoring Solutions: Remote patient monitoring (RPM) is a rapidly growing segment of the telemedicine market, enabling healthcare providers to track patients' vital signs and health data remotely. Net Medical Xpress Solutions can develop and offer RPM solutions that integrate with its Telemed platform, allowing for real-time monitoring and proactive intervention. This can improve patient outcomes, reduce hospital readmissions, and generate additional revenue. The RPM market is projected to reach $178.5 billion by 2027.
- Geographic Expansion: Net Medical Xpress Solutions currently focuses on the US market. Expanding into international markets, particularly in regions with limited access to healthcare, can provide significant growth opportunities. Adapting the Telemed platform to meet the specific needs and regulatory requirements of different countries will be crucial for success. Focusing on countries with government initiatives to promote telemedicine adoption could be a strategic approach.
- Integration of Artificial Intelligence (AI) and Machine Learning (ML): Incorporating AI and ML technologies into the Telemed platform can enhance its capabilities and improve patient outcomes. AI-powered diagnostic tools, personalized treatment recommendations, and automated administrative tasks can streamline workflows and reduce costs. By leveraging AI and ML, Net Medical Xpress Solutions can differentiate itself from competitors and attract clients seeking innovative telemedicine solutions. The AI in healthcare market is projected to reach $95 billion by 2030.
Fırsatlar
- Growing demand for telemedicine services driven by increasing healthcare costs and access challenges.
- Expansion into new medical specialties and geographic markets.
- Development of remote patient monitoring solutions.
- Integration of AI and machine learning to enhance the Telemed platform.
Tehditler
- Intense competition from established telemedicine providers.
- Evolving regulatory landscape for telemedicine.
- Potential cybersecurity risks associated with remote healthcare delivery.
- Reimbursement challenges for telemedicine services.
Rekabet Avantajları
- Proprietary Telemed Platform: The Telemed platform provides a customizable telemedicine management system.
- Integration Capabilities: Integration with approximately 43 hospital-based EMR systems creates switching costs for customers.
- Specialized Telemedicine Services: Focus on specific areas like teleneurology and telecardiology provides expertise and differentiation.
- FDA-Cleared Image Viewers: FDA clearance provides a level of credibility and regulatory compliance.
NMXS Hakkında
Founded in 1995 and based in Albuquerque, New Mexico, Net Medical Xpress Solutions, Inc., formerly known as New Mexico Software, Inc., has evolved into a telemedicine solutions provider. The company's core offering is its Telemed platform, a customizable telemedicine management system designed for hospitals, nursing homes, specialty hospitals, and other medical facilities. This platform supports a range of services, including teleneurology, teleneurosurgery, telecardiology, teleorthopedics, telewoundcare, and telenephrology. Net Medical Xpress Solutions provides a suite of tools and services, including digital paper, a development engine, single pane of glass software, and FDA-cleared image viewers. The company emphasizes integration, offering connectivity with approximately 43 hospital-based EMR systems. Beyond its technology platform, Net Medical Xpress Solutions provides physicians, administrative services (credentialing, program management, and call center management), and integration services such as electronic prescription software, prior authorization software, laboratory services, malpractice insurance, large-scale provider scheduling, medical translation, and rounding services. Additionally, the company offers staffing and recruiting services, diagnostic and clinical services, and Amazon cloud services. Net Medical Xpress Solutions aims to provide a comprehensive telemedicine solution, addressing both the technological and operational aspects of remote healthcare delivery.
Ne Yaparlar
- Provides a Telemed telemedicine platform for customized telemedicine management.
- Offers teleneurology, teleneurosurgery, telecardiology, teleorthopedics, telewoundcare, and telenephrology services.
- Develops digital paper, development engine, and single pane of glass software.
- Offers FDA-cleared image viewers.
- Integrates with approximately 43 hospital-based EMR systems.
- Provides telemedicine video conferencing equipment and USB clinical tools.
- Offers administrative services, such as credentialing, program management, and call center management.
İş Modeli
- Software as a Service (SaaS): Charges subscription fees for access to the Telemed platform.
- Service Fees: Generates revenue from providing telemedicine services, such as teleneurology and telecardiology.
- Integration Services: Earns revenue from integrating the Telemed platform with hospital EMR systems and other healthcare IT solutions.
- Staffing and Recruiting: Offers staffing and recruiting services for medical professionals.
Sektör Bağlamı
Net Medical Xpress Solutions operates within the healthcare information services industry, a sector experiencing growth due to increasing demand for remote patient monitoring and telehealth solutions. The telemedicine market is projected to continue expanding as healthcare providers seek to improve access, reduce costs, and enhance patient outcomes. However, the industry is competitive, with established players and emerging startups vying for market share. Net Medical Xpress Solutions faces competition from companies like BBLNF (BioAdaptives, Inc.), CVHIF (CareView Communications, Inc.), CYPS (Cypsa), EMGE (Emageon), and LCDX (Lucidia Health), each offering various telemedicine solutions and services.
Kilit Müşteriler
- Hospitals
- Nursing Homes
- Specialty Hospitals
- Other Medical Facilities
Finansallar
Grafik & Bilgi
Net Medical Xpress Solutions, Inc. (NMXS) hisse senedi fiyatı: Price data unavailable
Son Haberler
NMXS için son haber bulunmamaktadır.
Analist Konsensüsü
Fikir Birliği Derecelendirmesi
NMXS için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.
Fiyat Hedefleri
NMXS için Wall Street fiyat hedefi analizi.
MoonshotScore
Bu puan ne anlama geliyor?
MoonshotScore, NMXS'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.
Yönetim: Teresa Dickey
CEO
Teresa Dickey serves as the CEO of Net Medical Xpress Solutions, Inc. Her background includes extensive experience in managing and growing technology-driven companies. She has a proven track record in strategic planning, business development, and operational management. Her leadership is focused on driving innovation and expanding the company's reach in the telemedicine market. She is responsible for overseeing all aspects of the company's operations, from product development to sales and marketing.
Sicil: Under Teresa Dickey's leadership, Net Medical Xpress Solutions has focused on expanding its Telemed platform and integrating it with various hospital EMR systems. She has also overseen the development of new telemedicine services and the expansion into new geographic markets. Her strategic decisions have aimed to position the company as a leading provider of telemedicine solutions. She manages 23 employees.
NMXS OTC Piyasa Bilgileri
The OTC Other tier, also known as the Pink Market, represents the lowest tier of over-the-counter (OTC) stocks. Companies in this tier often have limited or no financial reporting requirements, making it difficult for investors to assess their financial health and operational performance. Listing on the OTC Other tier is typically associated with higher risk compared to stocks listed on major exchanges like the NYSE or NASDAQ, due to the lack of regulatory oversight and transparency. These companies may be early-stage ventures, financially distressed entities, or foreign companies with limited US presence.
- OTC Katmanı: OTC Other
- Açıklama Durumu: Unknown
- Limited Financial Disclosure: Lack of regular financial reporting increases the difficulty of assessing the company's financial health.
- Low Liquidity: Low trading volume and wide bid-ask spreads can make it difficult to buy or sell shares.
- Increased Volatility: OTC stocks are generally more volatile than those listed on major exchanges.
- Potential for Fraud or Manipulation: The lack of regulatory oversight increases the risk of fraudulent or manipulative activities.
- Going Concern Risk: Companies on the OTC Other tier may be facing financial difficulties and have a higher risk of going out of business.
- Verify the company's registration and legal standing.
- Obtain and review any available financial statements.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Research any past legal or regulatory issues.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- FDA clearance for image viewers suggests regulatory compliance.
- Integration with approximately 43 hospital-based EMR systems indicates market acceptance.
- Presence of a CEO (Teresa Dickey) and a management team.
- Years in business since 1995 suggests some level of operational history.
- Focus on telemedicine, a growing and potentially lucrative market.
NMXS Healthcare Hisse Senedi SSS
NMXS için değerlendirilmesi gereken temel faktörler nelerdir?
Net Medical Xpress Solutions, Inc. (NMXS) şu anda yapay zeka skoru 39/100, düşük puanı gösteriyor. Temel güçlü yan: Specialized telemedicine services in areas like teleneurology and telecardiology.. İzlenmesi gereken birincil risk: Ongoing: Negative profit margin and gross margin indicate financial instability.. Bu bir finansal tavsiye değildir.
NMXS MoonshotScore'u nedir?
NMXS şu anda MoonshotScore'da 39/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.
NMXS verileri ne sıklıkla güncellenir?
NMXS fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.
Analistler NMXS hakkında ne diyor?
NMXS için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.
NMXS'a yatırım yapmanın riskleri nelerdir?
NMXS için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Ongoing: Negative profit margin and gross margin indicate financial instability.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.
NMXS'ın P/E oranı nedir?
NMXS için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için NMXS'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.
NMXS aşırı değerli mi, yoksa düşük değerli mi?
Net Medical Xpress Solutions, Inc. (NMXS)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.
NMXS'ın temettü verimi nedir?
Net Medical Xpress Solutions, Inc. (NMXS) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.
Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.
Resmi Kaynaklar
Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.
- Limited information available on OTC-listed companies.
- Financial data may not be fully up-to-date.